Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma
byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T
Updated on: November 09,2024
0
Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma
byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T
Updated on:November 09,2024
0